Physician profile
Chen Wu
NPI 1285138289
$5,963.26
in general payments reported to CMS, 2019-2025
35 companies · $1,696 in 2025
The $1,696 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $163 · 2021: $490 · 2022: $234 · 2023: $1,385 · 2024: $1,995 · 2025: $1,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,648 · Education: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,648.47 |
| Education | $427.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $798.72 | 2023-2025 | Botox, Ubrelvy, Qulipta |
| Alexion Pharmaceuticals, INC. | $761.08 | 2020-2024 | Ultomiris |
| Jazz Pharmaceuticals INC. | $510.17 | 2023-2025 | |
| Eisai INC. | $415.95 | 2020-2025 | |
| Inspire Medical Systems, INC. | $406.68 | 2023-2025 | Inspire |
| Pfizer INC. | $372.18 | 2023-2025 | |
| Emd Serono, INC. | $314.38 | 2023-2024 | Mavenclad |
| Lundbeck LLC | $304.10 | 2023-2025 | Vyepti |
| Ucb, INC. | $268.70 | 2023 | Nayzilam, Briviact |
| Amgen INC. | $211.52 | 2024-2025 | Uplizna |
| Harmony Biosciences LLC | $188.52 | 2024-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $156.18 | 2023-2025 | Lumryz |
| Novartis Pharmaceuticals Corporation | $145.83 | 2023-2025 | |
| Biogen, INC. | $119.97 | 2023-2025 | Leqembi, Skyclarys, Qalsody |
| Neurocrine Biosciences, INC. | $118.01 | 2023-2025 | Ongentys, Ingrezza |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $111.30 | 2022 | |
| Sk Life Science, INC. | $92.96 | 2024-2025 | |
| Ge Healthcare | $88.16 | 2023-2024 | |
| Teva Pharmaceuticals USA, INC. | $67.09 | 2023-2025 | Ajovy |
| Tg Therapeutics, INC. | $65.98 | 2023-2025 | |
| Cala Health, INC. | $54.27 | 2025 | Cala Kiq |
| Lilly USA, LLC | $48.35 | 2025 | Kisunla, Amyvid, Zepbound |
| Currax Pharmaceuticals LLC | $45.63 | 2024 | Onzetra Xsail |
| Amneal Pharmaceuticals LLC | $43.66 | 2024 | Rytary, Crexont |
| Genentech USA, INC. | $42.08 | 2023 | Ocrevus |
| Boston Scientific Corporation | $40.69 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Axsome Therapeutics, INC. | $34.07 | 2025 | Symbravo |
| Tonix Medicines, INC. | $24.62 | 2025 | Zembrace Symtouch |
| Impel Pharmaceuticals INC. | $20.30 | 2023 | Trudhesa |
| Acadia Pharmaceuticals INC | $17.41 | 2025 | Nuplazid |
| Aucta Pharmaceuticals, INC. | $16.47 | 2024 | Motpoly Xr |
| Azurity Pharmaceuticals, INC. | $15.85 | 2025 | |
| Celgene Corporation | $14.34 | 2025 | Zeposia |
| Csl Behring | $14.15 | 2023 | Hizentra |
| Argenx US, INC. | $13.89 | 2024 | Vyvgart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chen Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.